Integral Health Asset Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Integral Health Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$902.69 - $993.35 $7.22 Million - $7.95 Million	-8,000 Reduced 32.0%	17,000 $16.4 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $19.4 Million - $22 Million	25,000 New	25,000 $22 Million
Q1 2023 May 09, 2023	BUY	$680.49 - $826.97 $2.04 Million - $2.48 Million	3,000 New	3,000 $2.47 Million
Q4 2021 Feb 02, 2022	SELL	$543.48 - $670.97 $5.43 Million - $6.71 Million	-10,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $4.88 Million - $5.79 Million	-8,500 Reduced 45.95%	10,000 $6.05 Million
Q2 2021 Aug 30, 2021	SELL	$472.8 - $558.54 $8.75 Million - $10.3 Million	-18,500 Reduced 50.0%	18,500 $10.3 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $17.5 Million - $20.7 Million	37,000 New	37,000 $20.7 Million
Q3 2020 Nov 16, 2020	SELL	$544.75 - $658.21 $6.54 Million - $7.9 Million	-12,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$493.32 - $643.92 $5.92 Million - $7.73 Million	12,000 New	12,000 $7.48 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.